Over the last few decades, immunotherapy has developed at a rapid rate in the treatment of cancer where neoantigens are the latest breakthrough in tumour immunotherapy. Today, it is still […]

SAE Media Group invites you to join the 14th Annual RNA Therapeutics Conference, taking place on 8 and 9 February 2023, in London, UK. Building on the success of previous […]

Introducing the only industry forum exclusively bringing together key decision-makers, within health insurers and providers, who are responsible for payment and revenue integrity, value-based payment, and networking relations. At a […]

6th Annual 3D Cell Culture Conference 8-9 February 2022 London, UK http://www.3D-cellculture.com/PJwl Sponsored: CelVivo, Promega and Systemic Bio Conference Co-chairs: Phillip Hewitt, Global Head of Early Investigative Toxicology, Merck Rhiannon David, […]

The 5th Annual CRISPR AgBio Congress will unite research heads, molecular biologists, regulatory experts, and product developers from large Ag companies, innovative AgBiotechs, academic groups and regulatory bodies to translate […]

Retinal Vascular Disease Drug Development Summit is an event dedicated to creating a community space dedicated to overcoming the current challenges in drug development for retinal vascular diseases. The management […]

 Join us in London this February to connect with those trailblazing the next wave of CAR and TCR based approaches from pre-clinical development with in vivo engineering and regulatory fast-track strategies to streamlined analytics and automation to make CAR […]

The past twelve months have seen an unprecedented level of excitement, investment, and progression within the gene therapy for muscular disorders field. As the industry endeavours to move gene therapy […]

Welcome to the 11th Alzheimer’s & Parkinson’s Drug Development Summit With a surge in preclinical investment, fresh news of clinical pipeline progressions, and a new era of therapies pending FDA approvals […]

Since Kinase inhibitors have proven to be efficacious and approvable targets, fuelling recent investment into this exciting space as their therapeutic targeting is explored beyond oncology. However, increasing resistance to […]

Achieve Therapeutic Localization with Selective, Effective & Validated Delivery to Intracellular Targets Optimize Your Pipeline’s Therapeutic Index with Novel Delivery Systems to Overcome Endosomal Barriers in Target Cells Selective cell […]

SAE Media Group is proud to present its 4th Annual AI in Drug Discovery Conference, taking place from 13 – 14 March 2023 in London, UK. With the recent pandemic […]

As the gene therapy field continues to break records, there are still significant challenges to overcome relating to safety, efficacy, and accessibility. The 6th Annual Gene Therapy for Rare Disorders […]

Patient-first. Collaborative. Data and insights driven. Digitally underpinned. These are the qualities of a healthcare system that actively serves its purpose – yet instead, the US is hindered by mounting […]

Dedicated to driving cost-effective, efficacious, safe, durable, scalable, and globally accessible allogeneic, cell-based, and engager therapies, the 8th Innate Killer Summit returns to cement your end-to-end education in innate immune therapeutics. […]

The first TCR-based therapy approval in the US and Europe at the start of last year sparked a rush of excitement, investment and collaborations. As further developers move into the […]

Hijacking E3 Ligases to Mediate Degradation & Modulation of Undrugged Targets As a family of over 600 known proteins, ligases pose immense potential as viable avenues for harnessing previously undrugged […]

Turbocharging Your Next Gen LNP End-To-End Development to Deliver Curative Promises to Patients Following exciting industry updates from Verve Therapeutics’ GalNAc-LNP for PCSK9 for HFpEF treatment, to Recode’s 5th element, […]

The field of FcRn receptor targeting is gaining ground-breaking speed as Argenx, Janssen, UCB and Immunovant compete to tackle myasthenia gravis and biopharma invest in transformative immunological therapy for autoimmune […]

mRNA therapeutics have catapulted into the limelight amidst the COVID-19 pandemic with multiple EMA approvals to help combat the virus. Bringing together KOLs sharing case studies with actionable insights, the […]

10th Annual Pre-Filled Syringes East Coast Conference April 24 – 25, 2023 Boston, USA Driving Innovations in Device Design, Connectivity and Sustainability for Advanced Parenteral Combination Product https://www.pfsamericas.com/PJ-Event-listing The 10th […]

Welcome to the Next Generation Cardiovascular Drug Development Summit Executing Cell & Gene Therapy for Cardiac Regeneration Following technology advancements and the surge of investment in developing the next generation […]

The 5th Annual Cell Engager Summit is back in Boston, MA this year – the only industry-led meeting bringing together 100+ pharma and biotech leaders will assemble for a 3-day agenda including 4 unique pre-conference […]

With increasing prioritization for neuroscience discovery, huge biopharma is investing in expanding its departments, focusing on glial biology, neuroinflammatory biomarkers, and optimizing various approaches to target the likes of LRKK2, […]

Uniting the leading minds in gene therapy at the Gene Therapy Durability Summit, join us to: Leverage knowledge from current clinical trials with relevant durability data across a range of […]

The 2nd ADC Analytical Development Summit (April 25-27, 2023 | Boston, MA) is the only meeting focused on optimizing the application of analytical technologies for ADC, from drug-linker and drug […]

6th Annual Pharmaceutical Microbiology USA Conference April 26 – 27, 2023 Boston, MA, USA http://www.pharma-microbiology-usa.com/PharmaJournalistWL Sponsored by: LONZA Chaired by: Donald Singer, USP General Chapter Committee Microbiology Chair, US Pharmacopeia  Contamination […]

Uniting leading CMC, Regulatory, QC, Analytical and Process Development experts, the 4th Annual Gene Analytical Development Europe Summit is the industry’s definitive and only meeting focused on tackling the greatest […]

Facilitating key conversations needed to drive forward the development of safe and effective innate stimulating immunotherapies, the 4th STING & TLR Targeting Therapies Summit will take place, for the first time […]

The Global High Potency API/HPAPI Market is projected to reach 37 billion USD by 2027, growing at an ever-increasing CAGR of 8.43%. The expanding production of high potency APIs, along […]